Observational studyFrontiers in immunology2024
Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series.
Jie Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled itcites it